JPMORGAN CHASE & CO - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is and the CUSIP is 88322Q908. A total of 4 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$296,000
-93.5%
50,000
-79.1%
0.00%
-100.0%
Q4 2021$4,552,000
+245.9%
239,600
+847.0%
0.00%
Q4 2020$1,316,000
+13.0%
25,300
-82.5%
0.00%
Q1 2019$1,165,000144,9000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Antara Capital LP 294,600$15,325,0003.18%
GROUP ONE TRADING, L.P. 758,500$39,457,0000.07%
SIMPLEX TRADING, LLC 560$2,913,0000.00%
JPMORGAN CHASE & CO 25,300$1,316,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of TG THERAPEUTICS INC shareholders